Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study

BACKGROUND: This analysis assessed baseline predictors of remission in patients with non-radiographic axial spondyloarthritis (nr-axSpA) who received open-label adalimumab therapy. METHODS: ABILITY-3 enrolled 673 adult patients with nr-axSpA who had objective evidence of inflammation by MRI or eleva...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieper, Joachim, Landewé, Robert, Magrey, Marina, Anderson, Jaclyn K, Zhong, Sheng, Wang, Xin, Lertratanakul, Apinya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560659/
https://www.ncbi.nlm.nih.gov/pubmed/31245052
http://dx.doi.org/10.1136/rmdopen-2019-000917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560659/
https://www.ncbi.nlm.nih.gov/pubmed/31245052
http://dx.doi.org/10.1136/rmdopen-2019-000917

Ejemplares similares